DoW Neurofibromatosis Exploration-Hypothesis Development Award
Status: Forecasted
Posted date: June 25, 2026
Archive date: October 22, 2026
Close date: September 22, 2026
Opportunity ID: 362976
Opportunity number: HT942526NFRPEHDA
Opportunity category: Discretionary
Agency name: Defense Health Agency Contracting Activity - DHACA
Agency code: DOD-AMRAA
Award floor: $0
Award ceiling: $0
Cost sharing required: No
Funding Instrument Types
- Grant
Category of Funding Activity
- Science and Technology and other Research and Development
Eligible Applicants
- Unrestricted
Categories (use these for quoted searches)
- agency_code:dod_amraa
- category_of_funding_activity:science_and_technology_and_other_research_and_development
- cost_sharing_or_matching_requirement:false
- eligible_applicants:unrestricted
- funding_instrument_type:grant
- opportunity_category:discretionary
- status:forecasted
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.Distinctive Features:• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.• Preliminary Data: Preliminary and/or published data is encouraged but not required.